<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25340262</article-id>
      <article-id pub-id-type="pmc">4214303</article-id>
      <article-id pub-id-type="publisher-id">14-0440</article-id>
      <article-id pub-id-type="doi">10.3201/eid2011.140440</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Letter</subject>
        </subj-group>
        <subj-group subj-group-type="TOC-title">
          <subject><italic>Helicobacter cinaedi</italic> Infection of Abdominal Aortic Aneurysm, Japan</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Helicobacter cinaedi</italic> Infection of Abdominal Aortic Aneurysm, Japan</article-title>
        <alt-title alt-title-type="running-head"><italic>H. cinaedi</italic> Infection, Japan</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kakuta</surname>
            <given-names>Risako</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yano</surname>
            <given-names>Hisakazu</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kanamori</surname>
            <given-names>Hajime</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shimizu</surname>
            <given-names>Takuya</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gu</surname>
            <given-names>Yoshiaki</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hatta</surname>
            <given-names>Masumitsu</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aoyagi</surname>
            <given-names>Tetsuji</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Endo</surname>
            <given-names>Shiro</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Inomata</surname>
            <given-names>Shinya</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oe</surname>
            <given-names>Chihiro</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tokuda</surname>
            <given-names>Koichi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ozawa</surname>
            <given-names>Daiki</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Goto</surname>
            <given-names>Hitoshi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Katori</surname>
            <given-names>Yukio</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kaku</surname>
            <given-names>Mitsuo</given-names>
          </name>
        </contrib>
        <aff id="aff1">Tohoku University Graduate School of Medicine, Sendai, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Risako Kakuta, Department of Infection Control and Laboratory Diagnostics, Tohoku University Graduate School of Medicine, 1-1 Seiryomachi, Aoba-ku, Sendai 980-8574, Japan; email: <email xlink:href="kakuta-r@med.tohoku.ac.jp">kakuta-r@med.tohoku.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <volume>20</volume>
      <issue>11</issue>
      <fpage>1942</fpage>
      <lpage>1945</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Infected abdominal aortic aneurysm</kwd>
        <kwd>IAAA</kwd>
        <kwd>
          <italic>Helicobacter cinaedi</italic>
        </kwd>
        <kwd>bacteria</kwd>
        <kwd>16S ribosomal RNA gene</kwd>
        <kwd>antibiotic</kwd>
        <kwd>antibacterial</kwd>
        <kwd>antimicrobial</kwd>
        <kwd>immunocompromised</kwd>
        <kwd>Japan</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Infected abdominal aortic aneurysm (IAAA) is uncommon, but life-threatening; the mortality rate ranges from 25% to30% (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>,<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). Identification of the pathogen is essential for diagnosis and treatment. Previous studies have shown that species of the genera <italic>Salmonella</italic>, <italic>Staphylococcus</italic>, and <italic>Streptococcus</italic> are the most common pathogens associated with IAAA, but a causative organism is not identified in 14%&#x2013;40% of patients (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>,<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). <italic>Helicobacter cinaedi</italic> has mainly been isolated from immunocompromised patients with bacteremia, cellulitis, and septic arthritis (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>,<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>). Here, we report 3 cases of IAAA caused by <italic>H. cinaedi</italic> detected by 16S ribosomal RNA (16S rRNA) gene analysis.</p>
    <p>The 3 patients (case-patients 1&#x2013;3) were referred to Tohoku University Hospital, Sendai, Japan, for surgical treatment of IAAA in 2013. None had a history of disease known to cause immunodeficiency. Because their abdominal aneurysms enlarged rapidly, all 3 patients underwent resection of the aneurysm and extensive local debridement and irrigation. Histopathologic examination of the surgical specimens revealed severe atherosclerosis and inflammation, consistent with a diagnosis of IAAA. For each case-patient, blood culture (BacT/ALERT; bioM&#xE9;rieux Industry, Tokyo, Japan) was negative, as was culture of surgically removed tissue on HK semisolid agar (Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan) at 35&#xB0;C under aerobic conditions for 7 days for enrichment of microorganisms, and on chocolate agar at 35&#xB0;C under 5% CO<sub>2</sub> for 48 h. We then used 16S rRNA gene analysis to identify a pathogen. We extracted DNA from resected tissues using a QIAamp DNA Mini kit (QIAGEN K.K., Tokyo, Japan), amplified it using PCR, and sequenced it using universal primers for 16S rRNA (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>). We used the EzTaxon-e Database for sequence analysis (<ext-link ext-link-type="uri" xlink:href="http://eztaxon-e.ezbiocloud.net/">http://eztaxon-e.ezbiocloud.net/</ext-link>), which revealed that the 16S rRNA gene sequence of bacteria in the aneurysmal tissues was identical to that of <italic>H. cinaedi</italic>. </p>
    <p>For case-patient 3, we cultured microaerophilic tissue at 35&#xB0;C using Trypticase Soy Agar II with 5% sheep blood (Kyokuto Pharmaceutical Industrial Co.) and an Anaero Pouch-MicroAero (Mitsubishi Gas Chemical Co., Inc., Tokyo, Japan) to detect <italic>H. cinaedi</italic>. We observed bacterial colonies, after Gram staining, which showed gram-negative spiral rods. By 16S rRNA gene analysis, we confirmed that the isolate was <italic>H. cinaedi</italic>. </p>
    <p>For each of the 3 case-patients, species identification was further confirmed by sequence analysis of 23S ribosomal RNA (23S rRNA) (DNA Data Bank of Japan: <ext-link ext-link-type="uri" xlink:href="http://blast.ddbj.nig.ac.jp/blastn?lang=ja">http://blast.ddbj.nig.ac.jp/blastn?lang&#xA0;=&#xA0;ja</ext-link>) and amplification of the <italic>gyrB</italic> gene region that is specific to <italic>H. cinaedi</italic> (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>,<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>). In samples from the 3 patients, there were mutations of the 23S rRNA gene and amino acid substitutions in GyrA related to macrolide and fluoroquinolone resistance, respectively (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>,<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>). After identifying the pathogen, we selected antimicrobial agents based on the reported drug susceptibility profile of <italic>H. cinaedi</italic> (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>,<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>). The patients survived and are being followed up as outpatients. Clinical and molecular characteristics of the 3 cases of IAAA with <italic>H. cinaedi</italic> infection are shown in the <xref ref-type="table" rid="T1">Table</xref>.</p>
    <table-wrap id="T1" position="float">
      <label>Table</label>
      <caption>
        <title>Clinical characteristics of 3 patients with <italic>Helicobacter cinaedi&#x2013;</italic>infected abdominal aortic aneurysms and molecular characteristics of isolates, Japan *</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="128" span="1"/>
        <col width="121" span="1"/>
        <col width="112" span="1"/>
        <col width="119" span="1"/>
        <thead>
          <tr>
            <th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Characteristic</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Case-patient 1</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Case-patient 2</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Case-patient 3</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, y/sex</td>
            <td valign="bottom" align="center" rowspan="1" colspan="1">64/M</td>
            <td valign="bottom" align="center" rowspan="1" colspan="1">59/M</td>
            <td valign="bottom" align="center" rowspan="1" colspan="1">62/M</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Underlying diseases</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Hypertension, hyperlipidemia</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">History of myocardial infarction</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Risk factors for infection</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Clinical signs and symptoms before surgery<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">Fever, back pain<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">Fever, abdominal pain<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">Low back pain<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="col" rowspan="1" colspan="1">CT results</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Site of aneurysm</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Infrarenal abdominal, bilateral common iliac, internal iliac, L femoral, aortic arch&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Infrarenal abdominal, bilateral common iliac</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Infrarenal abdominal</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Inflammatory findings around &#x2028; aneurysms<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">+<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">+<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">+<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Maximum leukocyte count/&#x3BC;L)/C-reactive protein, mg/dL before operation</td>
            <td valign="top" align="center" rowspan="1" colspan="1">10,600/25.3</td>
            <td valign="top" align="center" rowspan="1" colspan="1">9,100/6.05</td>
            <td valign="top" align="center" rowspan="1" colspan="1">7,050/ 5.29</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Surgical management<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">In situ grafting<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">In situ grafting<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">In situ grafting<hr/></td>
          </tr>
          <tr>
            <td colspan="4" valign="top" align="left" scope="col" rowspan="1">Microbiological diagnosis</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Blood culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Tissue culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">+&#x2021;</td>
          </tr>
          <tr>
            <td colspan="4" valign="top" align="left" scope="col" rowspan="1"> rRNA gene sequence similarity, %&#xA7;</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; 16S</td>
            <td valign="top" align="center" rowspan="1" colspan="1">99.8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">99.6</td>
            <td valign="top" align="center" rowspan="1" colspan="1">99.6</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; 23S</td>
            <td valign="top" align="center" rowspan="1" colspan="1">99.8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">99.8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">99.8</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Amplification of <italic>gyrB</italic> specific to &#x2028; <italic>H. cinaedi</italic></td>
            <td valign="top" align="center" rowspan="1" colspan="1">+</td>
            <td valign="top" align="center" rowspan="1" colspan="1">+</td>
            <td valign="top" align="center" rowspan="1" colspan="1">+</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Aneurysms in which <italic>H. cinaedi</italic> &#x2028; was identified<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">Infrarenal abdominal, L common iliac, R internal iliac, L femoral<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">Infrarenal abdominal<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">Infrarenal abdominal<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">MLST</td>
            <td valign="top" align="center" rowspan="1" colspan="1">ST15 (CC7)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">ST10 (CC9)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">ST10 (CC9)</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mutation of 23S rRNA gene and amino acid substitutions in GyrA<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">2018 A&#x2192;G and T84I D88G<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">2018 A&#x2192;G and T84I<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">2018 A&#x2192;G and T84I<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Antimicrobial therapy dosage and duration</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Before admission</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Ceftriaxone, 2 g/d, and levofloxacin, 500 mg/d, for 2 d</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Piperacillin/tazobactam, 4.5 g/d for 12 d; faropenem sodium hydrate, 600 mg/d for 10 d</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Oral antimicrobial agent, 4 d</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> After admission</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Doripenem, 1.5 g/d for 22 d, and vancomycin, 3.0 g/d, for 14 d</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Piperacillin/tazobactam, 4.5 g/d for 28 d</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Doripenem, 1.5 g/d for 28 d</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> After identification of pathogen</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Sulbactam/ampicillin, 3.0 g/d, and minocycline, 100 mg/d for 25 d</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Continuation of piperacillin/tazobactam</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Continuation of doripenem</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> At discharge<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">Oral amoxicillin, 1,500 mg/d, and minocycline, 200 mg/d, until follow-up visit<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">Oral amoxicillin, 1,500 mg/d, and minocycline, 200 mg/d, until follow-up visit<hr/></td>
            <td valign="top" align="center" rowspan="1" colspan="1">Oral amoxicillin, 1,500 mg/d, and minocycline, 200 mg/d, until follow-up visit<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Postoperative complications</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Outcome</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <p>*CT, computed tomography; +, positive; &#x2013;, negative; L, left; R, right; MLST, multilocus sequence typing; ST, sequence type; CC, clonal complex; A, adenine; G, guanine; T, threonine; I, isoleucine; D, aspartic acid; G, glycine.&#x2028;&#x2020;Aortic arch was replaced 5 weeks after the abdominal operation.&#x2028;&#x2021;Species unidentifiable under microaerophilic conditions.&#x2028;&#xA7;Compared with the type strain of <italic>H. cinaedi</italic> (CCUG 18818).</p>
      </table-wrap-foot>
    </table-wrap>
    <p>Although the high negative culture rate for pathogens causing IAAA had been explained by prolonged preoperative antimicrobial drug therapy (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>), another possibility is that <italic>H. cinaedi</italic> may be a causative organism. Earlier research has suggested that <italic>H. cinaedi</italic> infections can remain undiagnosed or be incorrectly diagnosed because of difficulty in isolating this microorganism (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>). <italic>H. cinaedi</italic> grows slowly under microaerophilic conditions, but no current standard laboratory methods result in a diagnosis of this pathogen (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>,<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>,<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>). We isolated <italic>H. cinaedi</italic> from surgically removed tissue from case-patient 3 by microaerophilic culture after taking this pathogen into consideration. For diagnosis of <italic>H. cinaedi</italic> infections, methods leading to accurate identification by clinical microbiological laboratories are needed. Currently, <italic>H. cinaedi</italic> is identified by molecular analysis of the 16S rRNA gene (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>,<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>,<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>). In addition, matrix-assisted laser desorption/ionization&#x2013;time-of-flight mass spectrometry (MALDI-TOF MS) (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>), may become a useful tool for this purpose. </p>
    <p>Standard breakpoints of antimicrobial drugs for <italic>H. cinaedi</italic> have not been defined, but all isolates in this study had mutations that indicated resistance to macrolides and fluoroquinolones. For adequate treatment for <italic>H. cinaedi</italic> infections, guidelines for selection of antimicrobial drugs and surveillance of its antimicrobial susceptibility profile are required.</p>
    <p>During November 2012&#x2013;November 2013, 8 patients underwent their first operation for IAAA at the university hospital. We used 16S rRNA gene analysis of surgical tissues and culture of blood and tissue specimens to detect pathogens (data not shown). Identification of <italic>H. cinaedi</italic> in 3 of 8 patients suggests that it could be a prevalent pathogen related to IAAA. Taking such information into consideration could affect the prognosis of many patients. Accordingly, tissue should be cultured while considering <italic>H. cinaedi</italic> infection in patients with IAAA. <italic>H. cinaedi</italic> colonizes the gastrointestinal tract, and bacterial translocation may lead to bacteremia associated with mucosal damage (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>). However, the route of transmission and reason most <italic>H. cinaedi</italic> infections have been reported in Japan are unclear. To clarify the relationship between <italic>H. cinaedi</italic> and IAAA, further clinical and epidemiologic studies are needed. Meanwhile, we recommend clinical consideration of <italic>H. cinaedi</italic> infection, use of appropriate laboratory procedures to identify cases, and development of treatment guidelines.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Kakuta R, Yano H, Kanamori H, Shimizu T, Gu Y, Hatta M, et al. <italic>Helicobacter cinaedi</italic> infection of abdominal aortic aneurysm, Japan [letter]. Emerg Infect Dis. 2014 Nov [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid2011.140440">http://dx.doi.org/10.3201/eid2011.140440</ext-link></p>
      </fn>
    </fn-group>
    <bio id="d35e681">
      <p>Dr Kakuta is an infectious disease and infection control doctor at Tohoku University Hospital, Sendai, Japan. Her research interests are clinical infectious diseases, infection control, and antimicrobial resistance.</p>
    </bio>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Miller</surname>
<given-names>DV</given-names></string-name>, <string-name><surname>Oderich</surname>
<given-names>GS</given-names></string-name>, <string-name><surname>Aubry</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Panneton</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>WD</given-names></string-name>. <article-title>Surgical pathology of infected aneurysms of the descending thoracic and abdominal aorta: clinicopathologic correlations in 29 cases (1976 to 1999).</article-title>
<source>Hum Pathol</source>. <year>2004</year>;<volume>35</volume>:<fpage>1112</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.humpath.2004.05.013</pub-id><pub-id pub-id-type="pmid">15343514</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="webpage"><string-name><surname>Laohapensang</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Aworn</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Orrapi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rutherford</surname>
<given-names>RB</given-names></string-name>. Management of the infected aortoiliac aneurysms. Ann Vasc Dis. <year>2012</year>;5:334&#x2013;41.<ext-link ext-link-type="uri" xlink:href="http://"/></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Lasry</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Simon</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Marais</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pouchot</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vinceneux</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Boussougant</surname>
<given-names>Y</given-names></string-name>. <article-title><italic>Helicobacter cinaedi</italic> septic arthritis and bacteremia in an immunocompetent patient.</article-title>
<source>Clin Infect Dis</source>. <year>2000</year>;<volume>31</volume>:<fpage>201</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1086/313930</pub-id><pub-id pub-id-type="pmid">10913427</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Araoka</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Baba</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kimura</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Abe</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Inagawa</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yoneyama</surname>
<given-names>A</given-names></string-name>. <article-title>Clinical characteristics of bacteremia caused by <italic>Helicobacter cinaedi</italic> and time required for blood cultures to become positive.</article-title>
<source>J Clin Microbiol</source>. <year>2014</year>;<volume>52</volume>:<fpage>1519</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00265-14</pub-id><pub-id pub-id-type="pmid">24574294</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>van Hung</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Hayashi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yoshida</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ohkusu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ezaki</surname>
<given-names>T</given-names></string-name>. <article-title>DnaJ sequences of <italic>Bacillus cereus</italic> strains isolated from outbreaks of hospital infection are highly similar to <italic>Bacillus anthracis.</italic></article-title>
<source>Diagn Microbiol Infect Dis</source>. <year>2011</year>;<volume>70</volume>:<fpage>307</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2011.02.012</pub-id><pub-id pub-id-type="pmid">21683265</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Rimbara</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mori</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Matsui</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wachino</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kawamura</surname>
<given-names>Y</given-names></string-name>, <etal/>
<article-title>Molecular epidemiologic analysis and antimicrobial resistance of <italic>Helicobacter cinaedi</italic> isolated from seven hospitals in Japan.</article-title>
<source>J Clin Microbiol</source>. <year>2012</year>;<volume>50</volume>:<fpage>2553</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.06810-11</pub-id><pub-id pub-id-type="pmid">22593597</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Minauchi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Takahashi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sakai</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kondo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shibayama</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Arakawa</surname>
<given-names>Y</given-names></string-name>, <etal/>
<article-title>The nosocomial transmission of <italic>Helicobacter cinaedi</italic> infections in immunocompromised patients.</article-title>
<source>Intern Med</source>. <year>2010</year>;<volume>49</volume>:<fpage>1733</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.2169/internalmedicine.49.3649</pub-id><pub-id pub-id-type="pmid">20720350</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Tomida</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Oumi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Okamoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Morita</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Okayama</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Misawa</surname>
<given-names>N</given-names></string-name>, <etal/>
<article-title>Comparative evaluation of agar dilution and broth microdilution methods for antibiotic susceptibility testing of <italic>Helicobacter cinaedi.</italic></article-title>
<source>Microbiol Immunol</source>. <year>2013</year>;<volume>57</volume>:<fpage>353</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/1348-0421.12044</pub-id><pub-id pub-id-type="pmid">23668607</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Oyama</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Okamoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Fujii</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ono</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Matsunaga</surname>
<given-names>T</given-names></string-name>, <etal/>
<article-title>Identification of and screening for human <italic>Helicobacter cinaedi</italic> infections and carriers via nested PCR.</article-title>
<source>J Clin Microbiol</source>. <year>2012</year>;<volume>50</volume>:<fpage>3893</fpage>&#x2013;<lpage>900</lpage> . <pub-id pub-id-type="doi">10.1128/JCM.01622-12</pub-id><pub-id pub-id-type="pmid">23015666</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Taniguchi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Sekiya</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Higa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Saeki</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Umeki</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Okayama</surname>
<given-names>A</given-names></string-name>, <etal/>
<article-title>Rapid identification and subtyping of <italic>Helicobacter cinaedi</italic> strains by intact-cell mass spectrometry profiling with the use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.</article-title>
<source>J Clin Microbiol</source>. <year>2014</year>;<volume>52</volume>:<fpage>95</fpage>&#x2013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.01798-13</pub-id><pub-id pub-id-type="pmid">24153128</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
